» Articles » PMID: 10599770

Gender Differences in the Incidence of AD and Vascular Dementia: The EURODEM Studies. EURODEM Incidence Research Group

Overview
Journal Neurology
Specialty Neurology
Date 1999 Dec 22
PMID 10599770
Citations 229
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To study the difference in risk for dementing diseases between men and women.

Background: Previous studies suggest women have a higher risk for dementia than men. However, these studies include small sample sizes, particularly in the older age groups, when the incidence of dementia is highest.

Methods: Pooled analysis of four population-based prospective cohort studies was performed. The sample included persons 65 years and older, 528 incident cases of dementia, and 28,768 person-years of follow-up. Incident cases were identified in a two-stage procedure in which the total cohort was screened for cognitive impairment, and screen positives underwent detailed diagnostic assessment. Dementia and main subtypes of AD and vascular dementia were diagnosed according to internationally accepted guidelines. Sex- and age-specific incidence rates, and relative and cumulative risks for total dementia, AD, and vascular dementia were calculated using log linear analysis and Poisson regression.

Results: There were significant gender differences in the incidence of AD after age 85 years. At 90 years of age, the rate was 81.7 (95% CI, 63.8 to 104.7) in women and 24.0 (95% CI, 10.3 to 55.6) in men. There were no gender differences in rates or risk for vascular dementia. The cumulative risk for 65-year-old women to develop AD at the age of 95 years was 0.22 compared with 0.09 for men. The cumulative risk for developing vascular dementia at the age of 95 years was similar for men and women (0.04).

Conclusion: Compared with men, women have an increased risk for AD. There are no gender differences in risk for vascular dementia.

Citing Articles

Menopausal symptom burden as a predictor of mid- to late-life cognitive function and mild behavioral impairment symptoms: A CAN-PROTECT study.

Crockford J, Guan D, Einstein G, Ballard C, Creese B, Corbett A PLoS One. 2025; 20(3):e0301165.

PMID: 40043017 PMC: 11882070. DOI: 10.1371/journal.pone.0301165.


Age- and Sex-Specific Regulation of Serine Racemase in the Retina of an Alzheimer's Disease Mouse.

Wang Y, Xu D, Zhao Y, Zhu H, Xiu X, Jiang H Invest Ophthalmol Vis Sci. 2025; 66(1):36.

PMID: 39813057 PMC: 11741067. DOI: 10.1167/iovs.66.1.36.


Predicting regional tau accumulation with machine learning-based tau-PET and advanced radiomics.

Rathore S, Higgins I, Wang J, Kennedy I, Iaccarino L, Burnham S Alzheimers Dement (N Y). 2025; 10(4):e70005.

PMID: 39748844 PMC: 11694527. DOI: 10.1002/trc2.70005.


Global burden of Alzheimer's disease and other dementias attributed to metabolic risks from 1990 to 2021: results from the global burden of disease study 2021.

Zhang X, Guo T, Zhang Y, Jiao M, Ji L, Dong Z BMC Psychiatry. 2024; 24(1):910.

PMID: 39696219 PMC: 11654253. DOI: 10.1186/s12888-024-06375-x.


Gene-dose-dependent reduction of Fshr expression improves spatial memory deficits in Alzheimer's mice.

Korkmaz F, Sims S, Sen F, Sultana F, Laurencin V, Cullen L Mol Psychiatry. 2024; .

PMID: 39548323 DOI: 10.1038/s41380-024-02824-x.